Pirouz M Daftarian

Title: Pirouz M Daftarian: Innovator in Cancer Treatment

Introduction

Pirouz M Daftarian is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and inventions. With a focus on utilizing liposomes in therapeutic applications, Daftarian has been instrumental in advancing medical technology.

Latest Patents

Daftarian holds 2 patents related to the use of liposomes in cancer treatment. His latest patents include compositions that utilize a continuous hydrophobic phase and liposomes as vehicles for delivering antigens capable of inducing a cytotoxic T lymphocyte (CTL) response. These inventions are aimed at improving the efficacy of cancer therapies and offer promising methods for their application in clinical settings.

Career Highlights

Throughout his career, Daftarian has been associated with Immunovaccine Technologies Inc., where he has played a crucial role in developing innovative solutions for cancer treatment. His work has garnered attention for its potential to enhance patient outcomes and provide new avenues for therapeutic interventions.

Collaborations

Daftarian has collaborated with notable colleagues, including Marc Mansour and Bill Pohajdak. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Pirouz M Daftarian is a distinguished inventor whose work in cancer treatment through liposome technology is paving the way for future innovations in the medical field. His contributions are vital in the ongoing fight against cancer, and his patents reflect a commitment to improving patient care.